BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 14708703)

  • 1. Treatment of chronic hepatitis B virus infection in patients co-infected with human immunodeficiency virus.
    Benhamou Y; Poynard T
    J Hepatol; 2003; 39 Suppl 1():S194-9. PubMed ID: 14708703
    [No Abstract]   [Full Text] [Related]  

  • 2. Activity of tenofovir on hepatitis B virus replication in HIV-co-infected patients failing or partially responding to lamivudine.
    Núñez M; Pérez-Olmeda M; Díaz B; Ríos P; González-Lahoz J; Soriano V
    AIDS; 2002 Nov; 16(17):2352-4. PubMed ID: 12441815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of hepatitis B virus infection in patients coinfected with HIV.
    Benhamou Y; Bonyhay L
    Gastroenterol Clin North Am; 2004 Sep; 33(3):617-27, x. PubMed ID: 15324947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New approaches in the treatment of hepatitis B].
    Sagir A; Avci A; Erhardt A; Lörke J; Heintges T; Häussinger D
    Dtsch Med Wochenschr; 2004 May; 129(21):1203-8. PubMed ID: 15160325
    [No Abstract]   [Full Text] [Related]  

  • 5. An open-label study of tenofovir in HIV-1 and Hepatitis B virus co-infected individuals.
    Nelson M; Portsmouth S; Stebbing J; Atkins M; Barr A; Matthews G; Pillay D; Fisher M; Bower M; Gazzard B
    AIDS; 2003 Jan; 17(1):F7-10. PubMed ID: 12478090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of chronic hepatitis B in the human immunodeficiency virus-infected patient: present and future.
    Núñez M; Puoti M; Camino N; Soriano V
    Clin Infect Dis; 2003 Dec; 37(12):1678-85. PubMed ID: 14689351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current knowledge on chronic hepatitis B therapy].
    Zoulim F; Werle B
    Gastroenterol Clin Biol; 2001 Apr; 25(4 Suppl):B143-51. PubMed ID: 11449155
    [No Abstract]   [Full Text] [Related]  

  • 8. [Current treatment of hepatitis B].
    Suárez García E; Romero Gómez M; Grande Santamaría L
    Gastroenterol Hepatol; 2001 Feb; 24 Suppl 1():35-50. PubMed ID: 11279893
    [No Abstract]   [Full Text] [Related]  

  • 9. Antiviral therapy for treatment-naïve hepatitis B virus patients.
    Lau DT; Membreno FE
    Gastroenterol Clin North Am; 2004 Sep; 33(3):581-99, ix-x. PubMed ID: 15324945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treating chronic lamivudine-resistant hepatitis B in HIV co-infected patients].
    Benhamou Y
    Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S22-5. PubMed ID: 17075492
    [No Abstract]   [Full Text] [Related]  

  • 11. Tenofovir disoproxil fumarate therapy for chronic hepatitis B in human immunodeficiency virus/hepatitis B virus-coinfected individuals for whom interferon-alpha and lamivudine therapy have failed.
    Ristig MB; Crippin J; Aberg JA; Powderly WG; Lisker-Melman M; Kessels L; Tebas P
    J Infect Dis; 2002 Dec; 186(12):1844-7. PubMed ID: 12447773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy for chronic hepatitis B.
    Schalm SW
    J Hepatol; 2003; 39 Suppl 1():S146-50. PubMed ID: 14708694
    [No Abstract]   [Full Text] [Related]  

  • 13. Tenofovir disoproxil fumarate for the treatment of hepatitis B infection.
    Adusumilli S
    Drugs Today (Barc); 2009 Sep; 45(9):679-85. PubMed ID: 19956809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV and hepatitis B virus: options for managing coinfection.
    Dieterich DT
    Top HIV Med; 2003; 11(1):16-9. PubMed ID: 12717046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The first nucleotide analog permitted. New hepatitis B therapy helps the problem patients, too].
    MMW Fortschr Med; 2003 Jun; 145(24):52. PubMed ID: 12866303
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatitis B virus related membranous glomerulonephritis and proteinuria treated with lamivudine and tenofovir.
    Das P; Vivek V; Ford M; Kingdon E; Holt S
    BMJ Case Rep; 2011 Aug; 2011():. PubMed ID: 22679045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New antiviral agent. Hepatitis B therapy with slight resistance risk].
    MMW Fortschr Med; 2003 Dec; 145(51-52):40. PubMed ID: 14974332
    [No Abstract]   [Full Text] [Related]  

  • 18. [Long-term therapy for chronic hepatitis B in HIV co-infected patients].
    Pais R; Benhamou Y
    Gastroenterol Clin Biol; 2010 Sep; 34 Suppl 2():S136-41. PubMed ID: 21095517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy of hepatitis B].
    Thimme R; Blum HE
    Praxis (Bern 1994); 2006 Sep; 95(36):1383-8. PubMed ID: 16989181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Managing resistance to analogue antiviral drugs in a decompensated cirrhosis patient].
    Zarski JP
    Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S20-1. PubMed ID: 17075491
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.